A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).
Por:
Howard SC, Davidson A, Luna-Fineman S, Israels T, Chantada G, Lam CG, Hunger SP, Bailey S, Ribeiro RC, Arora RS, Pedrosa F, Harif M and Metzger ML
Publicada:
1 dic 2017
Resumen:
Many children with cancer in low- and middle-income countries are treated in hospitals lacking key infrastructure, including diagnostic capabilities, imaging modalities, treatment components, supportive care, and personnel. Childhood cancer treatment regimens adapted to local conditions provide an opportunity to cure as many children as possible with the available resources, while working to improve services and supportive care. This paper from the Adapted Treatment Regimens Working Group of the Pediatric Oncology in Developing Countries committee of the International Society of Pediatric Oncology outlines the design, development, implementation, and evaluation of adapted regimens and specifies levels of services needed to deliver them.
Filiaciones:
Howard SC:
University of Tennessee Health Sciences Center, Memphis, Tennessee
Davidson A:
Haematology-Oncology Service, Red Cross Children's Hospital, Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa
Luna-Fineman S:
Hematology/Oncology/SCT, Center for Global Health, Children, Children's Hospital Colorado, University of Colorado, Aurora, Colorado
Israels T:
Department of Paediatric Oncology, VU University Medical Centre, Amsterdam, The Netherlands
Chantada G:
Hemato-Oncology Service, Hospital Sant Joan de Deu, Universitat de Barcelona, Barcelona, Spain
Pediatric Hemato-Oncology, Hospitals JP Garrahan and Austral, Buenos Aires, Argentina
CONICET, Buenos Aires, Argentina
Lam CG:
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
Hunger SP:
Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
Bailey S:
Paediatric Neuro-Oncology and Paediatric Oncology, Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
Ribeiro RC:
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
Arora RS:
Department of Medical Oncology, Max Super-Specialty Hospital, New Delhi, India
Pedrosa F:
Real Oncopediatria, Real Hospital Portugues, Recife, Brazil
Harif M:
Department of Hematology, Hopital 20 aout, Casablanca, Morocco
Metzger ML:
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
Open Access
|